The cultivation and manufacturing of antibodies can be challenging in multiple aspects such as process and analytical issues, production yield and purity. Our process and analytical development platform for antibodies and ADCs supports mass production in a cost-effective manner.

Our process and analytical development platform includes the following main functionalities: (i) the construction of GMP-compliant cell banks; (ii) the separation and purification process which improves product purity; and (iii) the analytical methods and detection technology for the biopharmaceutical characteristics of antibodies.

Leveraging our process and analytical development platform, our Company has optimized the manufacturing process of our pipeline products HX008 and LP002, which have demonstrated promising safety and efficacy profiles in clinical studies.